Brief: Vicore Pharma Holding Q4 Operating Loss Widens To SEK 30.2 Million
28/02/2020 07:17
Feb 28 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* Q4 OPERATING LOSS SEK 30.2 MILLION VERSUS LOSS SEK 13.6
MILLION
YEAR AGO
* BOARD OF DIRECTORS PROPOSES TO ANNUAL GENERAL MEETING THAT
NO
DIVIDEND SHOULD BE PAID FOR FINANCIAL YEAR 2019
Source text for Eikon: ID:nWkrbqGhZQ
Further company coverage: VICOR.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2